Ethris Announces Collaboration with DIOSynVax and CEPI to Develop a Broadly Protective ...

Retrieved on: 2022-12-21 10:03:18

Tags for this article:

Viruses

Medicine

Medical specialties

Severe acute respiratory syndrome–related coronavirus

Betacoronavirus

Coronavirus

Vaccine

Coalition for Epidemic Preparedness Innovations

Severe acute respiratory syndrome

Ethris GmbH

Click the tags to see associated articles and topics

Ethris Announces Collaboration with DIOSynVax and CEPI to Develop a Broadly Protective .... View article details on HISWAI: https://markets.financialcontent.com/stocks/article/bizwire-2022-12-21-ethris-announces-collaboration-with-diosynvax-and-cepi-to-develop-a-broadly-protective-mrna-vaccine-against-betacoronaviruses

Excerpt

Ethris GmbH, a leading biotechnology company pioneering next-generation messenger RNA (mRNA) therapeutics and vaccines, announced today a ...

Article found on: markets.financialcontent.com

View Original Article